close

Register today to unlock Valuecruncher and get unlimited access

  • Get unlimited access to all compartors and data
  • Save and share valuations as well as comment on others
  • Alter and save your favourite comparator companies

Already registered? Please login now

Comparison Analysis (switch to Discounted Cash Flow Analysis)
Dollar32Point78
Implied share price

Sell Overvalued by 57.0%

5% margin of safety What's this?

EV / EBITDA
Use Average
GENZ
Genzyme Corporation
AMGN
Amgen, Inc.
Change
GILD
Gilead Sciences, Inc.
Change
DNA
Genentech, Inc.
Change
SNY
Sanofi SA (ADR)
Change
9.92 23.69 12.21 4.95 17.08 5.09
All amounts in millions
from last financial year
         
Implied Share Price $32.78 $141.23 $169.44 $56.52 $80.16
Market Cap 18,291 130,102 107,921 100,042 98,744
Net Debt -371 47 7,450 -3,369 7,330
Enterprise Value (EV) 18,961 130,149 115,371 96,673 56,725
Revenue 4,048 21,662 32,639 13,418 34,861
EBITDA 800 10,657 23,287 5,661 11,136
Percent 19.8 % 49.2 % 71.3 % 42.2 % 31.9 %
EBIT 332 8,530 22,189 5,069 7,186
Percent 8.2 % 39.4 % 68.0 % 37.8 % 20.6 %
Balance Sheet          
Total Assets 10,913 71,449 51,716 21,787 102,321
Total Liabilities 3,326 43,366 33,182 6,116 44,272
Shareholders Equity 7,586 28,083 18,534 15,671 58,049.0

Comments

No comments yet. Login to comment.